Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.
Revision as of 00:36, 22 May 2026 by MDElliottMD (talk | contribs) (Category taxonomy ship: retag Addiction Medicine -> Anti-addiction agents)
Psychedelic, Dissociative
Ibogaine

Experience

👥 No personal reports yet
No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Interactions

No interactions reported yet.

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Summary
Classes
Psychedelic, Dissociative
Common uses
Pharmacy
Pharmacology
Purported mechanism
Kappa-opioid agonist; NMDA antagonist; SERT/DAT/NET inhibitor


Pendell's corner
Iboga's alkaloid in pure form does what the root bark does, but it does it pharmaceutically, in milligram doses, in clinics that bill insurance. The Bwiti gave the world the Ally; the pharmacologists gave the world the molecule; the question of how to give people the initiation without the village remains open.
— Dale Pendell, Pharmako/Gnosis
curated paraphrase — replace with verbatim passage